Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22
Grey-market BPC-157 is sold without independent certificates of analysis, and the FDA has specifically flagged contamination, mischaracterisation, and impurity risk for compounded peptides as a class
The risk may be increased if this product is used for an extended time, especially in newborns or in people with kidney disease
Seeking Medical Guidance Before Using Unlicensed Peptides in the UK Consult your GP before using any unlicensed peptide
Consult a healthcare professional if you: Have Asthma or Severe Allergies Some forms of glutathione, especially inhaled or intravenous, may trigger bronchial (air passages of the lungs) irritation or worsen asthma symptoms in sensitive individuals
History [edit] Descriptions of deficiency effects [edit] Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy
US$ 23.83
US$ 26.26
US$ 28.17
US$ 29.31